| (21 intermediate revisions by one other user not shown) | |||
| Line 17: | Line 17: | ||
<script src="https://2019.igem.org/Team:Bielefeld-CeBiTec/script.js?debug=false&lang=en&modules=jquery%2Cmediawiki&only=scripts&skin=igem&version=20161104T193904Z"></script> | <script src="https://2019.igem.org/Team:Bielefeld-CeBiTec/script.js?debug=false&lang=en&modules=jquery%2Cmediawiki&only=scripts&skin=igem&version=20161104T193904Z"></script> | ||
| + | <link rel="shortcut icon" href="https://2019.igem.org/wiki/images/7/71/T--Bielefeld-CeBiTec--favicon.png"> | ||
| + | |||
| + | <script type="text/javascript"> | ||
| + | |||
| + | /*! Image Map Resizer | ||
| + | * Desc: Resize HTML imageMap to scaled image. | ||
| + | * Copyright: (c) 2014-15 David J. Bradshaw - dave@bradshaw.net | ||
| + | * License: MIT | ||
| + | */ | ||
| + | |||
| + | |||
| + | ;(function() { | ||
| + | 'use strict' | ||
| + | |||
| + | |||
| + | function scaleImageMap() { | ||
| + | function resizeMap() { | ||
| + | function resizeAreaTag(cachedAreaCoords, idx) { | ||
| + | function scale(coord) { | ||
| + | var dimension = 1 === (isWidth = 1 - isWidth) ? 'width' : 'height' | ||
| + | return ( | ||
| + | padding[dimension] + | ||
| + | Math.floor(Number(coord) * scalingFactor[dimension]) | ||
| + | ) | ||
| + | } | ||
| + | |||
| + | var isWidth = 0 | ||
| + | areas[idx].coords = cachedAreaCoords | ||
| + | .split(',') | ||
| + | .map(scale) | ||
| + | .join(',') | ||
| + | } | ||
| + | |||
| + | var scalingFactor = { | ||
| + | width: image.width / image.naturalWidth, | ||
| + | height: image.height / image.naturalHeight, | ||
| + | } | ||
| + | |||
| + | var padding = { | ||
| + | width: parseInt( | ||
| + | window.getComputedStyle(image, null).getPropertyValue('padding-left'), | ||
| + | 10 | ||
| + | ), | ||
| + | height: parseInt( | ||
| + | window.getComputedStyle(image, null).getPropertyValue('padding-top'), | ||
| + | 10 | ||
| + | ), | ||
| + | } | ||
| + | |||
| + | cachedAreaCoordsArray.forEach(resizeAreaTag) | ||
| + | } | ||
| + | |||
| + | function getCoords(e) { | ||
| + | //Normalize coord-string to csv format without any space chars | ||
| + | return e.coords.replace(/ *, */g, ',').replace(/ +/g, ',') | ||
| + | } | ||
| + | |||
| + | function debounce() { | ||
| + | clearTimeout(timer) | ||
| + | timer = setTimeout(resizeMap, 250) | ||
| + | } | ||
| + | |||
| + | function start() { | ||
| + | if ( | ||
| + | image.width !== image.naturalWidth || | ||
| + | image.height !== image.naturalHeight | ||
| + | ) { | ||
| + | resizeMap() | ||
| + | } | ||
| + | } | ||
| + | |||
| + | function addEventListeners() { | ||
| + | image.addEventListener('load', resizeMap, false) //Detect late image loads in IE11 | ||
| + | window.addEventListener('focus', resizeMap, false) //Cope with window being resized whilst on another tab | ||
| + | window.addEventListener('resize', debounce, false) | ||
| + | window.addEventListener('readystatechange', resizeMap, false) | ||
| + | document.addEventListener('fullscreenchange', resizeMap, false) | ||
| + | } | ||
| + | |||
| + | function beenHere() { | ||
| + | return 'function' === typeof map._resize | ||
| + | } | ||
| + | |||
| + | function getImg(name) { | ||
| + | return document.querySelector('img[usemap="' + name + '"]') | ||
| + | } | ||
| + | |||
| + | function setup() { | ||
| + | areas = map.getElementsByTagName('area') | ||
| + | cachedAreaCoordsArray = Array.prototype.map.call(areas, getCoords) | ||
| + | image = getImg('#' + map.name) || getImg(map.name) | ||
| + | map._resize = resizeMap //Bind resize method to HTML map element | ||
| + | } | ||
| + | |||
| + | var /*jshint validthis:true */ | ||
| + | map = this, | ||
| + | areas = null, | ||
| + | cachedAreaCoordsArray = null, | ||
| + | image = null, | ||
| + | timer = null | ||
| + | |||
| + | if (!beenHere()) { | ||
| + | setup() | ||
| + | addEventListeners() | ||
| + | start() | ||
| + | } else { | ||
| + | map._resize() //Already setup, so just resize map | ||
| + | } | ||
| + | } | ||
| + | |||
| + | function factory() { | ||
| + | function chkMap(element) { | ||
| + | if (!element.tagName) { | ||
| + | throw new TypeError('Object is not a valid DOM element') | ||
| + | } else if ('MAP' !== element.tagName.toUpperCase()) { | ||
| + | throw new TypeError( | ||
| + | 'Expected <MAP> tag, found <' + element.tagName + '>.' | ||
| + | ) | ||
| + | } | ||
| + | } | ||
| + | |||
| + | function init(element) { | ||
| + | if (element) { | ||
| + | chkMap(element) | ||
| + | scaleImageMap.call(element) | ||
| + | maps.push(element) | ||
| + | } | ||
| + | } | ||
| + | |||
| + | var maps | ||
| + | |||
| + | return function imageMapResizeF(target) { | ||
| + | maps = [] // Only return maps from this call | ||
| + | |||
| + | switch (typeof target) { | ||
| + | case 'undefined': | ||
| + | case 'string': | ||
| + | Array.prototype.forEach.call( | ||
| + | document.querySelectorAll(target || 'map'), | ||
| + | init | ||
| + | ) | ||
| + | break | ||
| + | case 'object': | ||
| + | init(target) | ||
| + | break | ||
| + | default: | ||
| + | throw new TypeError('Unexpected data type (' + typeof target + ').') | ||
| + | } | ||
| + | |||
| + | return maps | ||
| + | } | ||
| + | } | ||
| + | |||
| + | /* | ||
| + | if (typeof define === 'function' && define.amd) { | ||
| + | define([], factory) | ||
| + | } else if (typeof module === 'object' && typeof module.exports === 'object') { | ||
| + | module.exports = factory() //Node for browserfy | ||
| + | } else { */ | ||
| + | window.imageMapResize = factory() | ||
| + | /* } */ | ||
| + | |||
| + | if ('jQuery' in window) { | ||
| + | window.jQuery.fn.imageMapResize = function $imageMapResizeF() { | ||
| + | return this.filter('map') | ||
| + | .each(scaleImageMap) | ||
| + | .end() | ||
| + | } | ||
| + | } | ||
| + | |||
| + | })() | ||
| + | |||
| + | </script> | ||
</head> | </head> | ||
| + | |||
| + | |||
<body> | <body> | ||
<div class="Wrapper"> | <div class="Wrapper"> | ||
| Line 41: | Line 216: | ||
<div class="dark"> | <div class="dark"> | ||
| + | |||
| + | |||
| + | <div class="center-fit"> | ||
| + | |||
| + | <map id="imgmap20191019235634" name="imgmap20191019235634"> | ||
| + | <area shape="circle" alt="" title="" coords="130,148,113" href="https://2019.igem.org/Team:Bielefeld-CeBiTec/Construction" target="_self" /> | ||
| + | <area shape="circle" alt="" title="" coords="337,314,123" href="https://2019.igem.org/Team:Bielefeld-CeBiTec/Endocytosis" target="_self" /> | ||
| + | <area shape="circle" alt="" title="" coords="524,138,114" href="https://2019.igem.org/Team:Bielefeld-CeBiTec/Demonstrate" target="_self" /> | ||
| + | <area shape="circle" alt="" title="" coords="817,91,74" href="https://2019.igem.org/Team:Bielefeld-CeBiTec/Hardware" target="_self" /> | ||
| + | <area shape="circle" alt="" title="" coords="845,336,109" href="https://2019.igem.org/Team:Bielefeld-CeBiTec/CeDIS" target="_self" /> | ||
| + | <area shape="circle" alt="" title="" coords="606,393,51" href="https://2019.igem.org/Team:Bielefeld-CeBiTec/Model" target="_self" /> | ||
| + | <area shape="poly" alt="" title="" coords="61,480,37,390,137,337,194,400,191,448,339,460,341,483,63,483" href="https://2019.igem.org/Team:Bielefeld-CeBiTec/Human_Practices" target="_self" /> | ||
| + | <!-- Created by Online Image Map Editor (http://www.maschek.hu/imagemap/index) --> | ||
| + | </map> | ||
| + | |||
| + | |||
| + | <figure class="figure large"> | ||
| + | <img class="figure image" src="https://2019.igem.org/wiki/images/1/15/T--Bielefeld-CeBiTec--overview_hp.png" usemap="#imgmap20191019235634"> | ||
| + | |||
| + | </figure> | ||
| + | |||
| + | |||
| + | </div> | ||
| + | |||
| + | |||
<div class="contentBlock"> | <div class="contentBlock"> | ||
| Line 74: | Line 274: | ||
</svg></div> | </svg></div> | ||
</td> | </td> | ||
| − | <td> <div class="space"> <a href="#h1"> | + | <td> <div class="space"> <a href="#h1"> Expert opinion </a> </div> </td> |
</tr> | </tr> | ||
| Line 88: | Line 288: | ||
</svg></div> | </svg></div> | ||
</td> | </td> | ||
| − | <td> <div class="space"> <a href="#h2"> | + | <td> <div class="space"> <a href="#h2"> Forward farm </a> </div> </td> |
</tr> | </tr> | ||
<tr id="memberPage"> | <tr id="memberPage"> | ||
| Line 101: | Line 301: | ||
</svg></div> | </svg></div> | ||
</td> | </td> | ||
| − | <td> <div class="space"> <a href="#h3"> | + | <td> <div class="space"> <a href="#h3"> Legal situation </a> </div> </td> |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
</tr> | </tr> | ||
</tbody> | </tbody> | ||
| Line 136: | Line 310: | ||
<div class="contentBlock"> | <div class="contentBlock"> | ||
| + | <a class="anchor" id="h1"></a> | ||
| + | <h1 id=a1>Expert opinions </h1> | ||
| + | <hr> <!--Blaue Linie--> | ||
<div id="rcorners1"> | <div id="rcorners1"> | ||
| − | + | <h1 style="margin-top:0px"> General Experts </h1> | |
| − | <h1 | + | |
<hr> <!--Blaue Linie--> | <hr> <!--Blaue Linie--> | ||
| Line 180: | Line 356: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/2/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/2/2d/T--Bielefeld-CeBiTec--HP_Proffessor_James_Brown.jpg"> |
<button class="collapsible colLeft"> <div id="HP"> <b style="color:#39F;"> Professor James Brown </b> <br> | <button class="collapsible colLeft"> <div id="HP"> <b style="color:#39F;"> Professor James Brown </b> <br> | ||
Group Leader – Plant Health <br> | Group Leader – Plant Health <br> | ||
| Line 212: | Line 388: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/e/ec/T--Bielefeld-CeBiTec--HP_Francismar_Marcelino-Guimaraes.jpg"> |
<button class="collapsible colRight"><div id="HP"> <b style="color:#39F;"> Dra. Francismar Corrêa Marcelino-Guimaraes</b> <br> | <button class="collapsible colRight"><div id="HP"> <b style="color:#39F;"> Dra. Francismar Corrêa Marcelino-Guimaraes</b> <br> | ||
Research and Development <br> | Research and Development <br> | ||
| Line 242: | Line 418: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/0/09/T--Bielefeld-CeBiTec--HP_Zabel_1.png"> |
<button class="collapsible colLeft"> <div id="HP"> <b style="color:#39F;"> Paul Zabel</b> <br> | <button class="collapsible colLeft"> <div id="HP"> <b style="color:#39F;"> Paul Zabel</b> <br> | ||
Research Associate at DLR working on the EDEN ISS project <br> | Research Associate at DLR working on the EDEN ISS project <br> | ||
| Line 315: | Line 491: | ||
--> | --> | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/c/c3/T--Bielefeld-CeBiTec--HP_Jha.jpeg"> |
<button class="collapsible colRight"><div id="HP"> <b style="color:#39F;">Gopaljee Jha </b> <br> | <button class="collapsible colRight"><div id="HP"> <b style="color:#39F;">Gopaljee Jha </b> <br> | ||
PhD. student <br> | PhD. student <br> | ||
| Line 355: | Line 531: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/9/90/T--Bielefeld-CeBiTec--HP_Kogel1.png"> |
<button class="collapsible colLeft"><div id="HP"> <b style="color:#39F;"> Prof. Dr. Karl-Heinz Kogel </b> <br> | <button class="collapsible colLeft"><div id="HP"> <b style="color:#39F;"> Prof. Dr. Karl-Heinz Kogel </b> <br> | ||
Head of the institute for Phytopathology <br> | Head of the institute for Phytopathology <br> | ||
| Line 406: | Line 582: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/6/61/T--Bielefeld-CeBiTec--HP_Wei-Xiong.jpg"> |
<button class="collapsible colRight"><div id="HP"> <b style="color:#39F;">Wei Xiong </b> <br> | <button class="collapsible colRight"><div id="HP"> <b style="color:#39F;">Wei Xiong </b> <br> | ||
Crop Modeler and Physiologist at CIMMYT’s Sustainable Intensification Program <br> | Crop Modeler and Physiologist at CIMMYT’s Sustainable Intensification Program <br> | ||
| Line 440: | Line 616: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/4/4f/T--Bielefeld-CeBiTec--HP_Korr.jpg"> |
<button class="collapsible colLeft"><div id="HP"> <b style="color:#39F;"> Prof. Dr. Verena Haberlah-Korr </b> <br> | <button class="collapsible colLeft"><div id="HP"> <b style="color:#39F;"> Prof. Dr. Verena Haberlah-Korr </b> <br> | ||
Prof. of plant production and protection <br> | Prof. of plant production and protection <br> | ||
| Line 479: | Line 655: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/7/71/T--Bielefeld-CeBiTec--HP_Langridge.jpeg"> |
<button class="collapsible colRight"><div id="HP"> <b style="color:#39F;"> Professor Peter Langridge </b> <br> | <button class="collapsible colRight"><div id="HP"> <b style="color:#39F;"> Professor Peter Langridge </b> <br> | ||
International Science Coordinator, Wheat Initiative <br> | International Science Coordinator, Wheat Initiative <br> | ||
| Line 515: | Line 691: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/f/f0/T--Bielefeld-CeBiTec--HP_Dr._Ravi_P._Singh.jpg"> |
<button class="collapsible colLeft"><div id="HP"> <b style="color:#39F;"> Dr. Ravi P. Singh </b> <br> | <button class="collapsible colLeft"><div id="HP"> <b style="color:#39F;"> Dr. Ravi P. Singh </b> <br> | ||
Distinguished Scientist - Head-Wheat Improvement Global Wheat Program <br> | Distinguished Scientist - Head-Wheat Improvement Global Wheat Program <br> | ||
| Line 542: | Line 718: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/4/4a/T--Bielefeld-CeBiTec--HP_Asdal.jpg"> |
<button class="collapsible colRight"><div id="HP"> <b style="color:#39F;">Åsmund Asdal </b> <br> | <button class="collapsible colRight"><div id="HP"> <b style="color:#39F;">Åsmund Asdal </b> <br> | ||
Coordinator of Operation and Management, NordGen <br> | Coordinator of Operation and Management, NordGen <br> | ||
| Line 576: | Line 752: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/7/7a/T--Bielefeld-CeBiTec--HP_Tscharntke.jpg"> |
<button class="collapsible colLeft"><div id="HP"> <b style="color:#39F;">Prof. Dr. Teja Tscharntke </b> <br> | <button class="collapsible colLeft"><div id="HP"> <b style="color:#39F;">Prof. Dr. Teja Tscharntke </b> <br> | ||
Department of Agroecology <br> | Department of Agroecology <br> | ||
| Line 607: | Line 783: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/7/74/T--Bielefeld-CeBiTec--HP_Schmitt.jpg"> |
<button class="collapsible colRight"><div id="HP"> <b style="color:#39F;">Prof. Dr. Lutz Schmitt </b> <br> | <button class="collapsible colRight"><div id="HP"> <b style="color:#39F;">Prof. Dr. Lutz Schmitt </b> <br> | ||
Chair of Biochemistry I <br> | Chair of Biochemistry I <br> | ||
| Line 641: | Line 817: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/c/c0/T--Bielefeld-CeBiTec--HP_Westhoff.jpeg"> |
<button class="collapsible colLeft"><div id="HP"> <b style="color:#39F;">(Univ.-) Prof. Dr. Peter Westhoff </b> <br> | <button class="collapsible colLeft"><div id="HP"> <b style="color:#39F;">(Univ.-) Prof. Dr. Peter Westhoff </b> <br> | ||
Vice President for Research and Technology Transfer <br> | Vice President for Research and Technology Transfer <br> | ||
| Line 673: | Line 849: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/7/7b/T--Bielefeld-CeBiTec--HP_Tessa.jpg"> |
<button class="collapsible colRight"><div id="HP"> <b style="color:#39F;">Tessa Alexanian </b> <br> | <button class="collapsible colRight"><div id="HP"> <b style="color:#39F;">Tessa Alexanian </b> <br> | ||
iGEM Human Practice Committee <br> | iGEM Human Practice Committee <br> | ||
| Line 707: | Line 883: | ||
<div id="rcorners3"> | <div id="rcorners3"> | ||
| − | + | ||
| − | <h1 | + | <h1 style="margin-top:0px; color:#330036"> Endocytosis </h1> |
<hr style="background-color:#330036"> <!--Blaue Linie--> | <hr style="background-color:#330036"> <!--Blaue Linie--> | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/c/c5/T--Bielefeld-CeBiTec--HP_Oliver.jpeg"> |
<button class="collapsible colRight"> <div id="HP"><b style="color:#39F;"> Prof. Richard Oliver</b> <br> | <button class="collapsible colRight"> <div id="HP"><b style="color:#39F;"> Prof. Richard Oliver</b> <br> | ||
Professor of Agriculture <br> | Professor of Agriculture <br> | ||
| Line 757: | Line 933: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/8/85/T--Bielefeld-CeBiTec--HP_Zeilinger.jpg"> |
<button class="collapsible colLeft"> <div id="HP"><b style="color:#39F">Prof. Dr. Susanne Zeilinger-Migsich </b> <br> | <button class="collapsible colLeft"> <div id="HP"><b style="color:#39F">Prof. Dr. Susanne Zeilinger-Migsich </b> <br> | ||
Deputy Head of the Department of Microbiology <br> | Deputy Head of the Department of Microbiology <br> | ||
| Line 791: | Line 967: | ||
</div> | </div> | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/f/f1/T--Bielefeld-CeBiTec--HP_Park.jpeg"> |
<button class="collapsible colRight"><div id="HP"> <b style=color:#39f> Prof. Robert Park </b> <br> | <button class="collapsible colRight"><div id="HP"> <b style=color:#39f> Prof. Robert Park </b> <br> | ||
Judith and David Coffey Chair of Sustainable Agriculture and | Judith and David Coffey Chair of Sustainable Agriculture and | ||
| Line 831: | Line 1,007: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/7/77/T--Bielefeld-CeBiTec--HP_Prof._Eduardo_Antonio_Espeso_Fernand%C3%A9z.png"> |
<button class="collapsible colLeft"><div id="HP"><b style="color:#39f">Prof. Eduardo Antonio Espeso Fernández </b> <br> | <button class="collapsible colLeft"><div id="HP"><b style="color:#39f">Prof. Eduardo Antonio Espeso Fernández </b> <br> | ||
Research Professor at the Dept. of Cellular and Molecular Biology <br> | Research Professor at the Dept. of Cellular and Molecular Biology <br> | ||
| Line 861: | Line 1,037: | ||
</div> | </div> | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/0/02/T--Bielefeld-CeBiTec--HP_Diallinas.jpg"> |
<button class="collapsible colRight"><div id="HP"><b style="color:#39f"> Prof. George Diallinas </b> <br> | <button class="collapsible colRight"><div id="HP"><b style="color:#39f"> Prof. George Diallinas </b> <br> | ||
Professor of Biology <br> | Professor of Biology <br> | ||
| Line 886: | Line 1,062: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/8/8b/T--Bielefeld-CeBiTec--HP_Hahn.jpeg"> |
<button class="collapsible colLeft"><div id="HP"><b style="color:#39F"> Prof. Dr. Matthias Hahn </b> <br> | <button class="collapsible colLeft"><div id="HP"><b style="color:#39F"> Prof. Dr. Matthias Hahn </b> <br> | ||
Professor of Phytopathology <br> | Professor of Phytopathology <br> | ||
| Line 919: | Line 1,095: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/2/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/2/2c/T--Bielefeld-CeBiTec--HP_Dr._Alexander_Lichius.jpg"> |
<button class="collapsible colRight"><div id="HP"> <b style="color:#39F">Dr. Alexander Lichius </b> <br> | <button class="collapsible colRight"><div id="HP"> <b style="color:#39F">Dr. Alexander Lichius </b> <br> | ||
Department of Microbiology <br> | Department of Microbiology <br> | ||
| Line 946: | Line 1,122: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/c/cd/T--Bielefeld-CeBiTec--HP_Gsaller.jpg"> |
<button class="collapsible colLeft"><div id="HP"> <b style="color:#39f;"> Fabio Gsaller PhD.</b> <br> | <button class="collapsible colLeft"><div id="HP"> <b style="color:#39f;"> Fabio Gsaller PhD.</b> <br> | ||
Institute of Molecular Biology <br> | Institute of Molecular Biology <br> | ||
| Line 986: | Line 1,162: | ||
<!--neues Feld--> | <!--neues Feld--> | ||
<div id="rcorners4"> | <div id="rcorners4"> | ||
| − | + | ||
| − | <h1 | + | <h1 style="margin-top:0px; color:#721356"> CeDIS </h1> |
<hr style="background-color:#721356"> <!--Blaue Linie--> | <hr style="background-color:#721356"> <!--Blaue Linie--> | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/8/85/T--Bielefeld-CeBiTec--HP_Schaffrath.jpg"> |
<button class="collapsible colRight"><div id="HP"><b style="color:#39f"> Prof. Dr. Ulrich Schaffrath</b> <br> | <button class="collapsible colRight"><div id="HP"><b style="color:#39f"> Prof. Dr. Ulrich Schaffrath</b> <br> | ||
Group leader Department of Plant Physiology <br> | Group leader Department of Plant Physiology <br> | ||
| Line 1,055: | Line 1,231: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/f/fe/T--Bielefeld-CeBiTec--HP_Krczal.jpg" alt="Bild hoffentlich rund"> |
<button class="collapsible colLeft"><div id="HP"> <b style="color:#39F"> Prof. Dr. Gabi Krczal </b> <br> | <button class="collapsible colLeft"><div id="HP"> <b style="color:#39F"> Prof. Dr. Gabi Krczal </b> <br> | ||
Director of AlPlanta – Institute of Plant Research <br> | Director of AlPlanta – Institute of Plant Research <br> | ||
| Line 1,096: | Line 1,272: | ||
</div> | </div> | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/e/e8/T--Bielefeld-CeBiTec--HP_Deising.jpg"> |
<button class="collapsible colRight"><div id="HP"><b style="color:#39f"> Prof. Holger Deising </b> <br> | <button class="collapsible colRight"><div id="HP"><b style="color:#39f"> Prof. Holger Deising </b> <br> | ||
Professor for Phytopathology and Plant Protection <br> | Professor for Phytopathology and Plant Protection <br> | ||
| Line 1,126: | Line 1,302: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/6/68/T--Bielefeld-CeBiTec--HP_Cox.jpeg"> |
<button class="collapsible colLeft"> <div id="HP"> <b style="color:#39f">Prof. Dr. Russel Cox </b> <br> | <button class="collapsible colLeft"> <div id="HP"> <b style="color:#39f">Prof. Dr. Russel Cox </b> <br> | ||
Research group leader – Synthetic Biology <br> | Research group leader – Synthetic Biology <br> | ||
| Line 1,166: | Line 1,342: | ||
<!--neues Feld--> | <!--neues Feld--> | ||
<div id="rcorners2"> | <div id="rcorners2"> | ||
| − | + | ||
| − | <h1 | + | <h1 style="margin-top:0px; color:#820933"> Demonstrate </h1> |
<hr style="background-color: #820933"> <!--Blaue Linie--> | <hr style="background-color: #820933"> <!--Blaue Linie--> | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/0/0e/T--Bielefeld-CeBiTec--HP_Dr._Primrose_J_Boynton.jpg"> |
<button class="collapsible colRight"><div id="HP"><b style="color:#39F"> Dr. Primrose Boynton </b> <br> | <button class="collapsible colRight"><div id="HP"><b style="color:#39F"> Dr. Primrose Boynton </b> <br> | ||
Project Leader <br> | Project Leader <br> | ||
| Line 1,199: | Line 1,375: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/d/db/T--Bielefeld-CeBiTec--HP_Kniemeyer.jpg"> |
<button class="collapsible colLeft"> <div id="HP"><b style="color:#39F"> Dr. Olaf Kniemeyer </b> <br> | <button class="collapsible colLeft"> <div id="HP"><b style="color:#39F"> Dr. Olaf Kniemeyer </b> <br> | ||
Molecular and Applied Microbiology · Deputy head of Department <br> | Molecular and Applied Microbiology · Deputy head of Department <br> | ||
| Line 1,237: | Line 1,413: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/e/e6/T--Bielefeld-CeBiTec--HP_Varrelmann.jpg"> |
<button class="collapsible colRight"><div id="HP"><b style="color:#39F">Prof. Dr. Mark Varrelmann </b> <br> | <button class="collapsible colRight"><div id="HP"><b style="color:#39F">Prof. Dr. Mark Varrelmann </b> <br> | ||
Research group leader - Phytomedicin <br> | Research group leader - Phytomedicin <br> | ||
| Line 1,275: | Line 1,451: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/2/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/2/26/T--Bielefeld-CeBiTec--HP_Annicka_Roos.jpg"> |
<button class="collapsible colLeft"> <div id="HP"><b style="color:#39F"> Annika Roos </b> <br> | <button class="collapsible colLeft"> <div id="HP"><b style="color:#39F"> Annika Roos </b> <br> | ||
Marketing consultant for wheat (Nordrhein-Westfalen) <br> | Marketing consultant for wheat (Nordrhein-Westfalen) <br> | ||
| Line 1,304: | Line 1,480: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/a/a6/T--Bielefeld-CeBiTec--HP_Fischer.jpeg"> |
<button class="collapsible colRight"><div id="HP"><b style="color:#39F"> Prof. Dr. Reinhard Fischer </b> <br> | <button class="collapsible colRight"><div id="HP"><b style="color:#39F"> Prof. Dr. Reinhard Fischer </b> <br> | ||
Professor at the Institute for Applied Biosciences, Department of Microbiology <br> | Professor at the Institute for Applied Biosciences, Department of Microbiology <br> | ||
| Line 1,340: | Line 1,516: | ||
<div id="rcorners5"> | <div id="rcorners5"> | ||
| − | + | ||
| − | <h1 | + | <h1 style="margin-top:0px; color:#0b5091"> Modeling </h1> |
<hr style="background-color:#0b5091"> <!--Blaue Linie--> | <hr style="background-color:#0b5091"> <!--Blaue Linie--> | ||
| Line 1,384: | Line 1,560: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/f/f6/T--Bielefeld-CeBiTec--HP_Sirven.jpg"> |
<button class="collapsible colLeft"> <div id="HP"> <b style="color:#39F">Catherine Sirven</b> <br> | <button class="collapsible colLeft"> <div id="HP"> <b style="color:#39F">Catherine Sirven</b> <br> | ||
Computational Life Science Portfolio <br> | Computational Life Science Portfolio <br> | ||
| Line 1,433: | Line 1,609: | ||
</div> | </div> | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/d/d9/T--Bielefeld-CeBiTec--HP_German.jpeg"> |
<button class="collapsible colRight"> <div id="HP"> <b style="color:#39F"> Prof. Silvia Germán </b> <br> | <button class="collapsible colRight"> <div id="HP"> <b style="color:#39F"> Prof. Silvia Germán </b> <br> | ||
Emeritus researcher at the National Agricultural Research Institute (INIA) of Uruguay <br> | Emeritus researcher at the National Agricultural Research Institute (INIA) of Uruguay <br> | ||
| Line 1,470: | Line 1,646: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/5/56/T--Bielefeld-CeBiTec--HP_Doohan.jpg"> |
<button class="collapsible colLeft"> <div id="HP"> <b style="color:#39F"> Prof. Fiona Doohan </b> <br> | <button class="collapsible colLeft"> <div id="HP"> <b style="color:#39F"> Prof. Fiona Doohan </b> <br> | ||
Professor at School of Biology and Environmental Science <br> | Professor at School of Biology and Environmental Science <br> | ||
| Line 1,503: | Line 1,679: | ||
<div id="rcorners6"> | <div id="rcorners6"> | ||
| − | + | ||
| − | <h1 | + | <h1 style="margin-top:0px; color:#7fb042"> Agriculture </h1> |
<hr style="background-color: #7fb042ff"> <!--Blaue Linie--> | <hr style="background-color: #7fb042ff"> <!--Blaue Linie--> | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/1/1f/T--Bielefeld-CeBiTec--HP_Guenther.jpeg"> |
<button class="collapsible colRight"><div id="HP"> <b style="color:#39F"> Susanne Günther </b> <br> | <button class="collapsible colRight"><div id="HP"> <b style="color:#39F"> Susanne Günther </b> <br> | ||
Philosopher, Editor and Farmer <br> | Philosopher, Editor and Farmer <br> | ||
| Line 1,548: | Line 1,724: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/ | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/4/47/T--Bielefeld-CeBiTec--HP_Kleimann.jpg" alt="Bild hoffentlich rund"> |
<button class="collapsible colLeft"> <div id="HP"> <b style="color:#39f"> Michael Kleimann</b> <br> | <button class="collapsible colLeft"> <div id="HP"> <b style="color:#39f"> Michael Kleimann</b> <br> | ||
Farmer <br> | Farmer <br> | ||
| Line 1,586: | Line 1,762: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/f/ff/T--Bielefeld-CeBiTec--HP_Waldschmidt.jpg" alt="Bild hoffentlich rund"> |
<button class="collapsible colRight"> <div id="HP"> <b style="color:#39f"> Kristina Waldschmidt </b> <br> | <button class="collapsible colRight"> <div id="HP"> <b style="color:#39f"> Kristina Waldschmidt </b> <br> | ||
Farmer <br> | Farmer <br> | ||
| Line 1,618: | Line 1,794: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundRight" src="https://2019.igem.org/wiki/images/2/2a/T--Bielefeld-CeBiTec-- | + | <img class="roundRight" src="https://2019.igem.org/wiki/images/2/2a/T--Bielefeld-CeBiTec--HP_Toebber.jpg"> |
<button class="collapsible colLeft"> <div id="HP"> <b style="color:#39F"> Theo Többer </b> <br> | <button class="collapsible colLeft"> <div id="HP"> <b style="color:#39F"> Theo Többer </b> <br> | ||
Farmer <br> | Farmer <br> | ||
| Line 1,653: | Line 1,829: | ||
<div class="hideDiv"> | <div class="hideDiv"> | ||
| − | <img class="roundLeft" src="https://2019.igem.org/wiki/images/2/ | + | <img class="roundLeft" src="https://2019.igem.org/wiki/images/2/2f/T--Bielefeld-CeBiTec--HP_Krainbring.jpg" alt="Bild hoffentlich rund"> |
<button class="collapsible colRight"><div id="HP"> <b style="color:#39F"> Phillip Krainbring </b> <br> | <button class="collapsible colRight"><div id="HP"> <b style="color:#39F"> Phillip Krainbring </b> <br> | ||
Farmer <br> | Farmer <br> | ||
| Line 1,718: | Line 1,894: | ||
</div> | </div> | ||
</div> | </div> | ||
| + | <a class="anchor" id="h2"></a> | ||
| + | <h1 id=a2>Forward Farm </h1> | ||
| + | <hr> <!--Blaue Linie--> | ||
| + | <div>On the 26th of September 2019, we visited the Bayer Forward Farm in Rommerskirchen </div> | ||
| + | <div>We visited the Bayer Forward Farm in Rommerskirchen, the “Damianshof” accompanied by Bernd Olligs (farmer and owner of the farm), Dr Patrick Beuters (Product Development Manager for fungicides in cereals, sugar beet and potatoes) and Karl Eschenbacher (Head of Bayer Forward Farming). <br> | ||
| + | The farm in Rommerskirchen is one of two locations in Germany where Bayer established a Forward Farm: An experimental testing area for novel approaches to solve problems in the field of agriculture. Thereby, the farm’s purpose is also to educate the public about farming and emerging technologies. The engagement with the public and the promotion of face to face interaction is one of the foundations the project is based on.<br> | ||
| + | During our visit, we received extensive first-hand insights into agriculture from different points of views. The different experts who accompanied us each represented a different important aspect of modern agriculture. </div> | ||
| + | <div> | ||
| + | <div class="middle"> | ||
| + | <figure class="figure large"> | ||
| + | <img class="figure image" src="https://2019.igem.org/wiki/images/c/c3/T--Bielefeld-CeBiTec--HP_FF_Gruppenbild_neu.JPG"> | ||
| + | </figure> | ||
| + | </div> | ||
| + | </div> | ||
| + | <h2>Dr Patrick Beuters</h2> | ||
| + | <div>He is in the department of Market Development Manager for fungicides in cereals, sugar beet and potatoes.</div> | ||
| + | <div class="third right"> | ||
| + | <figure class="figure large"> | ||
| + | <img class="figure image" src="https://2019.igem.org/wiki/images/4/46/T--Bielefeld-CeBiTec--HP_Beuters.jpg"> | ||
| + | </figure> </div> | ||
| + | <div>Dr Patrick Beuters gave us insights into the importance of fungicides for agriculture. As a consultant for fungicides for cereals, sugar beet and potatoes he has an extensive overview about all their important products and modes of actions. | ||
| + | His explanations regarding the history and recent change in usage of fungicides as well as the latest interests in research completed the depictions of Karl Eschenbacher and Bernd Olligs very well. | ||
| + | At the same time, he stressed the need to investigate alternatives to meet future challenges. Furthermore, he showed us the extend of the recent interests of the industry for new alternatives, e.g. biologics. | ||
| + | According to Dr Beuters, it is important to work closely with farmers to ensure proper use of fungicides and effective food safety. | ||
| + | </div> | ||
| + | |||
| + | <h2>Karl Eschenbacher</h2> | ||
| + | <div>He is Head of Bayer Forward Farming.</div> | ||
| + | <div class="third left"> | ||
| + | <figure class="figure large"> | ||
| + | <img class="figure image" src="https://2019.igem.org/wiki/images/6/66/T--Bielefeld-CeBiTec--KarlEschenbacher.jpg"> | ||
| + | </figure> | ||
| + | |||
| + | </div> | ||
| + | <div>Karl Eschenbacher is the Supervisor Head of Bayer Forward Farming in Germany. He stressed the importance of a close cooperation between industry, farmer and consumer. A lack of understanding can easily lead to problems and misconceptions according to him. | ||
| + | He explained how valuable open communication about agricultural measures are to educate people about the necessity of certain methods and applications, e.g. the use of pesticides. | ||
| + | To reduce prejudices towards agriculture, engagement and education with the public are among the greatest tools to achieve a well-understood, fair-regulated, sustainable and safe food production. | ||
| + | Considering we live in a time, where technological advancements are achieved quickly and should be easily accessible and understood by the public, engagement with everyday people is often sparse. An open conversation about such topics and new approaches to communicate the subject in a target group specific manner can really make a difference. | ||
| + | To sum up, Karl Eschenbacher clarified how important well-informed consumers are to achieve an integrated agriculture. | ||
| + | </div> | ||
| + | |||
| + | <h2>Bernd Olligs</h2> | ||
| + | <div>Is the farmer that is taking care of the farm Damianshof, where the forward farm is located</div> | ||
| + | <div class="half right"> | ||
| + | <figure class="figure large"> | ||
| + | <img class="figure image" src="https://2019.igem.org/wiki/images/9/98/T--Bielefeld-CeBiTec--HP_Bernd_3.jpg"> | ||
| + | </figure> | ||
| + | </div> | ||
| + | <div> | ||
| + | Bernd Olligs is the owner of the farm. He gave us great first-hand insight into the work as a farmer. He showed us how full of meaningful decisions his work is and underlined his statements with stories and anecdotes from his work. | ||
| + | His depictions of the life as a farmer made us realise how underestimated and unappreciated the work of farmers is in modern society and how complex the issues can be that they are confronted by. They have to assure a maximum yield while minimizing the costs and the impact on the environment while planning years far ahead. This is a task unmatched in modern society. | ||
| + | During our visit, Bernd Olligs also described the importance of improving the personal contact between farmers and consumers to create a broader understanding of the reasons that drive their decisions and our dependency on their experience. | ||
| + | </div> | ||
| + | |||
| + | <a class="anchor" id="h3"></a> | ||
| + | <h1 id=a3>Legal Situation </h1> | ||
| + | <hr> <!--Blaue Linie--> | ||
| + | <div class=""> | ||
| + | |||
| + | <div> | ||
| + | For our project and especially its real world applications, the regulations on Genetically Modified Organisms (GMOs) and their release matter. | ||
| + | To assess whether using Troygenics within agriculture is feasible in certain countries we looked into their legal situation regarding GMOs. Working together with the iGEM team of UFRGS Brazil we assessed the legal situation of 10 countries. | ||
| + | We also discussed possible future changes in the EU regulations with Felix Beck, a PhD student at the institute of public law at the university of Freiburg and an expert on the European biotechnology law. | ||
| + | Additionally, after discussing the use of our system with Cécile J.B. van der Vlugt of the National Institute for Public Health and the Environment (RIVM) of the Netherlands, we looked into the regulations on risk assessments for releasing GMOs within the EU. | ||
| + | During these considerations of the legal situation, we learned that using our Troygenics in agriculture is not possible yet - neither in the EU, nor in any of the other countries we looked into. | ||
| + | Moreover, we would encourage release of Troygenics or a system alike prior to performing thorough and tidyous risk assessments to make sure that potential forseeable and unforseeable damage to the environment can be avoided. | ||
| + | </div> | ||
| + | |||
| + | |||
| + | <div class="center"> | ||
| + | <figure class="figure large"> | ||
| + | <img class="figure image" src="https://2019.igem.org/wiki/images/2/2e/T--Bielefeld-CeBiTec--GMO_Table_Worldwide.png"> | ||
| + | <figcaption>Legal situation in 10 countries: number of GM crop varieties that can legally be grown, area on which GM crops are cultivated, minimal time required for the approval of GM crops, minimal number of authorities invested in the approval of GM crops and obligatory labelling of GM products in supermarkets. | ||
| + | Sources on the bottom of the page. | ||
| + | </figcaption> | ||
| + | </figure> | ||
| + | </div> | ||
| + | |||
| + | <div> <h1>Legal situation: Point of view <br> </h1></div> | ||
| + | |||
| + | <div> | ||
| + | <br> | ||
| + | <h3>Point of View: Germany</h3> | ||
| + | Coming from Germany, a country that strictly regulates the use of GMOs under any circumstances and does not allow any genetically modified organisms to be released, it was rather surprising, that there are countries that don’t only allow the release of GMOs, but have more than 100 kinds of genetically modified crops on the market. | ||
| + | It was rather startling that in the USA the use of 130 genetically modified plants is not regulated anymore and that companies do not have to get permits or even notify the government that and where they are planting those GMOs. It left us even more surprised that there are several thousand more GMOs on the fields in the USA that are monitored and are not used in food, feed or any other application just yet. | ||
| + | The fact that there are Genetically Modified Microorganisms (GMMs) with an authorization for release at all, totaling to 39 in Brazil and Australia, was another surprise to us. The rules set for risk assessments in the EU make it rather unlikely that a GMM would pass the regulatory process, no matter how many safety measures have been taken to construct a save organism and to prevent its spreading. Coming from a precautionary point of view, the tedious risk assessments ensure safety – and as unlikely as any negative consequences of releasing a GMM into the environment might be, the EU wants to prevent them without any doubt. Since eliminating the doubt is only possible, if the organism is not released, this is the option the EU usually choses. Seeing that other countries accept and live with that doubt, left us startled – most Germans would not be okay with those policies. | ||
| + | Another thing that was rather new to us was that countries as the USA and Canada do not enforce the labeling of products that contain GMOs. While we are insecure about the clarity of the definition of GMO and the awareness that the regular consumer has towards this definition, transparency is considered to be incredibly important for democracy in Germany and in the EU. Even though the acts of authorities don’t always live up to the high expectancies for transparency among the people, this is often called out and complained about. Therefore, labeling the origin of products in the supermarket is important to many Germans, allowing for a more informed consumer decision. | ||
| + | Whether this should also be true for GMO-products has to be discussed, mostly due to the varying definition of GMOs all over the world. Is an organism that is produced with random mutagenesis genetically modified? How about a cross-bred plant? What if a CRISPR/Cas system had been used? The definitions are different depending on the law – and vary even more widely on the minds of consumers. If a consumer does not properly understand a label, labeling GMO products might not lead to a more, but rather a less informed choice. | ||
| + | However, we do believe that some kind of labeling, be it GMO or non-GMO or naming the plant variety that had been used might help the consumer to make an informed decision. That the legal situation in other countries enables the selling of GMO products without labeling them might be another approach that would not be accepted by many Germans due to the lack of transparency and the impact that this might have on their informed decisions. | ||
| + | </div> | ||
| + | |||
| + | <div> | ||
| + | <br> | ||
| + | <h3>Point of View: Brazil</h3> | ||
| + | In Brazil, we’re used to GM crops, since over 50 Million hectares are destined to growing GM crops. Recently, approval of agrochemicals mainly destined to GM cultivations, such as glyphosate-based herbicides in the news frequently. Furthermore, labelling GM products is mandatory in Brazil and is often discussed in recent times. | ||
| + | Overall, we find it very difficult to find data about GMOs. We expected this would be easier given its importance for food as well as for the development of new technologies in health and for the environment. | ||
| + | Considering the high number of GMO crops and the application of GMMs and even GM animals in Brazil the legislation is one of the most flexible in the world, allowing GMOs use, different from what we thought, due to the general bureaucracy in the country. | ||
| + | The most remarkable feature in the GMO legislation for Australia is the restriction of GMO crop cultivation, since 61% of the Australian landmass is not suitalbe for agricultural production. Therefore, using GM crops to improve the production efficiency might be interesting for the country. | ||
| + | We knew that GMO legislation in the European Union is much stricter than the one we have in Brazil, so we expected that no transgenic plants would be grown in Sweden and England, and that the labelling of GMO products would be mandatory in both countries. | ||
| + | We find it amazing that there is a lot of research on GMMs in Swedish high schools. Besides that, we were stunned when reading about the case of the Amflora potato in the country. Approval took a long time when the swedes began producing it, the crops were contaminated by another unauthorized GMO potato. Therefore, they stopped growing the potato and the responsible company stopped all further activities in the country! This is not common in Brazil: when an environmental disaster happens, the responsible companies do not shut down… | ||
| + | When reading about the UK, we were surprised by Boris Johnson's recent quote about the GMO production there: “Let's liberate the UK's extraordinary bioscience sector from anti-genetic modification rules." We did not imagine this stance, as there is a strong anti-GMO culture in the UK and all current crop cultivations are non-transgenic. May this be the starting point for Europe to change its mind about GMOs? | ||
| + | It was surprising to us that Egypt forbids GMO cultivation, although it imports many GMOs varieties. Given its arid climate, we were sure that there would be some GMO production that would dodge this circumstance. In addition, the anti-GMO mindset appears to be quite strong, as well as incidences of illegal use of toxic substances in agricultural production. | ||
| + | Regarding India, we found it impressive that the governing laws about GMOs were very old: from 1989. However, it is not always respected, and the problems of irreversible cross-contamination due to the illegal cultivation of other GMO varieties are recurrent. We were surprised that the only variety allowed for cultivation is cotton. In addition, we think it is progressive for the country to allow research with Oxitec and GM silkworms mosquitoes. | ||
| + | It was unexpected to find that Canada does not require mandatory labelling of genetically modified foods. It is voluntary, unless there is an explicit health or safety concern. As one of the main producers of GM crops, there are movements of those in the country who believe the labelling should be mandatory. | ||
| + | On the other hand, it was interesting to find that China - also one of the largest producers of GM crops - needs, on average, much less time to get a GMO approved, even though the project has to go through three main institutions to do so. Makes us wonder about the bureaucracy in other countries, that require 7 to 11 years to get a GM crop approved such as in Brazil. Furthermore, as a study from 2018 points out, almost half of the Chinese population have a negative perception of genetically modified foods, which may explain the mandatory labelling of GM foods in the country. | ||
| + | |||
| + | </div> | ||
| + | |||
| + | <div style="display: inline-grid;"> | ||
| + | <h2> GMO legislations in several countries </h2> </div> | ||
| + | |||
| + | |||
| + | <div> | ||
| + | <button class="collapsible" id="Info"> China </button> | ||
| + | |||
| + | <div class="content" id="addInfo"> | ||
| + | According to the data published by the MOA on April 27, 2013, China has issued GMO Safety Certificates to seven domestically developed, genetically modified (GM) crops, including a varieties of tomato (1997), cotton (1997), petunia (1999), sweet pepper and chili pepper (1999), papaya (2006), rice (2009), and corn (2009). Among them, the approved cotton has been broadly cultivated in China. As of 2010, China grew 3.3 million hectares of the approved cotton and a few hectares of the papaya, while the other GM crops had not been cultivated broadly, according to the MOA.[10] | ||
| + | An International Service for the Acquisition of Agri-Biotech Applications brief, Global Status of Commercialized Biotech/GM Crops: 2012, indicates that China grew 4.0 million hectares of GM crops, including cotton, papaya, poplar, tomato, and sweet pepper, as of 2012, which constituted the largest biotech crop area among developing countries, and the sixth largest around the world.[11] | ||
| + | Licenses have been granted for the import into China of four foreign GM crops: cotton, soybean, corn, and rape. Among them, only the cotton is permitted to be grown in China; the other crops can only be used as raw materials, according to the MOA.[12] In 2011, imported GM soybeans constituted two-thirds of the soybeans consumed domestically.[13] | ||
| + | </div> | ||
| + | |||
| + | </div> | ||
| + | |||
| + | |||
| + | <div> | ||
| + | <button class="collapsible" id="Info"> India </button> | ||
| + | |||
| + | <div class="content" id="addInfo"> | ||
| + | In India, all genetically modified organism and products are regulated by the “Rules for the Manufacture, Use/Import/Export and Storage of Hazardous Micro Organisms/Genetically Engineered Organisms or Cells, commonly referred to as 'Rules 1989'. | ||
| + | There are currently 11 different transgenic cotton crops being produced. Although their cultivation was released in 2002, it was marked by controversy: Bt cotton suffered a spate of pink bollworms, and the liberation of GMO cotton is also linked to socioeconomical problems, due to conflicts with the tradicional cotton production. Currently, there are also recurring problems of illegal GMO crops cultivation, such as Bt brinjal, bringing risks to the country's biodiversity. | ||
| + | Research involving GM microorganisms is ocurring in several parts of the country. The Oxitec mosquito has been developed in India with successfull matings with local strains, as well as GE silkworms, both being contained trials. | ||
| + | Commercial GM Crops area: the world’s fifth largest cultivated area under genetically modified (GM) crops, at 11.4 million hectares (mh) in 2017. | ||
| + | |||
| + | </div> | ||
| + | |||
| + | </div> | ||
| + | |||
| + | <div> | ||
| + | <button class="collapsible" id="Info"> Egypt </button> | ||
| + | |||
| + | <div class="content" id="addInfo"> | ||
| + | Egypt is in the process of developing a regulatory framework to conduct safety assessments about GMOs. The Food Safety Agency of Egypt (NFSA) is recent, having been established in 2017. It shall particularly establish the protocols for procedures, rules of registration, licensing and handling of genetically modified food, according to Codex Alimentarius Commission standards adopted by international bodies. | ||
| + | At the moment, Egypt only produces GMOs food for research purposes, and allows GMOs imports upon authorization. In the country, there is a big clash involving the cultivation or not of GMOs, as can be seen in the case of 2018, where an aridity-resistant wheat was not released on the market. Until January 2018, there was still no law that organizes and regulates the production, circulation and use of genetically modified organisms or the control of genetic engineering research, even though the project was developed in govermental science sectors. | ||
| + | </div> | ||
| + | |||
| + | </div> | ||
| + | |||
| + | <div> | ||
| + | <button class="collapsible" id="Info"> Sweden </button> | ||
| + | |||
| + | <div class="content" id="addInfo"> | ||
| + | Sweden states that for the realisation of activities with genetically modified organisms, a risk assessment must be sent to the Swedish Work Environment Authority. Swedish law has added an ethical aspect to its GMO regulations that EU directives do not have, which stipulates that the use and application of GMOs should be done with ethical considerations (Riksdagen.se, 2017; Habibi, 2018). Sweden has grown only once a transgenic organism: the Amflora potato. Its activities ended in 2012, when another GM potato not approved for commercial use mixed in the field trials (Habibi, 2018). GM crops are currently grown in field trials and also in greenhouses and laboratories (Habibi, 2018). In relation to GMMs, most GMM-activities are research related (472), followed by commercial use (73) and high schools research (14). | ||
| + | </div> | ||
| + | |||
| + | </div> | ||
| + | |||
| + | <div> | ||
| + | <button class="collapsible" id="Info"> Australia </button> | ||
| + | |||
| + | <div class="content" id="addInfo"> | ||
| + | In Australia the most remarkable feature is the restriction of GMO crops, once 61% of the australian landmass is for agricultural production, this could improve these production. About Australia, one of the most remarkable points was the disagreement of some number on different databases. While on ISAAA database there are 135 GM Crop Events approved, once they consider events that are not allowed for commercialization, on the Australian Office of the Gene Technology Regulator website, there are only 23 GM crops allowed for commercialization and only one species, canola, for human nutrition. Thus showing us how the data source can lead to misunderstandings, even dealing with public and open-access information. We can also conclude that Australia has an intermediary acceptance of the GMOs use. | ||
| + | </div> | ||
| + | |||
| + | </div> | ||
| + | |||
| + | <div> | ||
| + | <button class="collapsible" id="Info"> USA </button> | ||
| + | |||
| + | <div class="content" id="addInfo"> | ||
| + | The United States of America are rather liberal when it comes to the cultivation of GMO crops. By 2018, 90% of all domestic corn, cotton, soybean, surgarbeet and canola fields were genetically modified. Most of them had an increased resistance towards herbicides or a higher insect resistance. 80% of corn and 82% of cotton had both. | ||
| + | In total, there are 130 genetically engineered crops that are unregulated and can therefore be planted, grown and shipped without requiring an additional permission. To acquire this status, the GM organism cannot have a risk of being a plant pest, it has to be safe for other organisms and for animal or human consumption, if one intends to use it for that. The testing is conducted by the companies that strive releasing the genetically engineered organism, but the evaluation of those risk assessments is conducted by national agencies: The Animal and Health Inspection Service (APHIS), the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA). | ||
| + | This year, APHIS suggested a new way of assessing the necessity of regulating genetically engineered organisms. They don’t want the method of engineering to be relevant, but the final traits of the organism. Therefore, plants transformed using plant pests should no longer be considered plant pests automatically and plants with similar genetic modifications as could be obtained in breeding, the plant pest risk should be considered equally high. | ||
| + | |||
| + | </div> | ||
| + | |||
| + | </div> | ||
| + | |||
| + | <div> | ||
| + | <button class="collapsible" id="Info"> Germany </button> | ||
| + | |||
| + | <div class="content" id="addInfo"> | ||
| + | In Germany, there are no GMOs that can be legally grown outside of the lab and can be used commercially. However, there are many GMOs that are cultivated in other countries and have been introduced in feed and food. They are considered to be safe for those purposes. | ||
| + | Additionally, there were times when the cultivation of the corn MON810 and the potato Amflora was legal in Germany. This changed when, for MON810, the limited authorization had to be renewed and while it’s still considered safe according to newer risk assessments on the EU level, Germany opted-out of the legalization. That happened in 2009. In 2012 the Ukraine sued against the cultivation of the Amflora potato in the EU due to procedural errors in the authorization process. BASF did not pursue a new authorization of the potato afterwards. | ||
| + | The question, what causes the strict regulations for the release of GMOs in Germany and the EU in general arises upon learning about these situations. | ||
| + | To understand where that comes from, one has to have a closer look at the procedure of GMOs in this area. | ||
| + | If a company or research group wants to get authorization for the release of GMOs in Germany, they have to get in touch with the German Federal Office for Consumer Protection and Food Safety and hand in their request for releasing the GMO. The Federal Office verifies the completeness of the request and asks for additional information if necessary. | ||
| + | When the Federal Office for Consumer Protection and Food safety is content with the amount of information, the public is informed about the planned release and can comment on the published plans over a timespan of four weeks. | ||
| + | At the same time, the Federal Office for Consumer Protection and Food Safety works together with established scientific institutions to conduct risk assessments of the impact on humans, animals and the environment. They also consider statements of the central commission for biological safety and the political leaders of the federal state in which the release shall take place. | ||
| + | Lastly, the EU is informed about the planned release. However, as long as it is not intended for commercial use, they do not get a say in the final decision. | ||
| + | Right now there is one authorized released event taking place: a whine plant with increased fungal resistance. The release was approved in 1999 and ends in December of 2019. If this period ends, there won’t be any GMOs legally released into the environment in Germany anymore. | ||
| + | There have been many more experimental releases within that time frame, however most of them ended in the early 2000s and no new authorizations for release were issued since 2012 – and those issued in 2012 all ended since. | ||
| + | |||
| + | </div> | ||
| + | |||
| + | </div> | ||
| + | |||
| + | <button class="collapsible" id="Info"> Brazil </button> | ||
| + | |||
| + | <div class="content" id="addInfo"> | ||
| + | Following the USA, Brazil grows GMO crops on the second largest area and has the second greatest GMO use in general. The crops are applied in feed, food and industry. Besides the plants, Brazil had approved several GM microorganisms (GMM), including agents for therapeutic purposes and industrial fermentation and bioproduction. Furthermore, a GM mosquito was developed in Brazil, and approved for release, used for populational control of Aedes aegypti mosquitoes. Considering the high number of GMO crops and the application of GMM and even GM animals in the legislation of Brazil, it is one of the most flexible countries when it comes to GMO use. | ||
| + | </div> | ||
| + | |||
| + | |||
| + | |||
| + | <button class="collapsible" id="Info"> United Kingdom </button> | ||
| + | |||
| + | <div class="content" id="addInfo"> | ||
| + | In the United Kingdom one has send an application directly to the European institution EFSA, while requests for research-related release of GMOs are evaluated at a national level. There is no commercial growth of GMOs, although the country imports GMO crops for animal feed. There have been experimental trials of GM potatoes, wheat and <i>Camila sativa</i> in the UK over the last years. Recently, Boris Johnson, the current UK Prime Minister, stated that he wants the UK to become a world leader in GM food technologies. This has caused great concern over the british farmers, whose plantations are still non-GMO. 881 installations with GMMs have been approved to date (December 2016). | ||
| + | </div> | ||
| + | |||
| + | |||
| + | |||
| + | <button class="collapsible" id="Info"> Canada </button> | ||
| + | |||
| + | <div class="content" id="addInfo"> | ||
| + | GM related subjects in Canada are regulated by “Health Canada”, and according to ISAAA, there are 183 GM Crop Events for 15 different species approved in the country. While the GM foods are mandatorily labeled in most countries, labeling the presence of GMOs in particular food is voluntary unless there is a health or safety concern in Canada. As one of the major producers of genetically modified crops in the world, Canada is facing issues, as many people in the country think GM foods may cause health problems and the labelling of GM foods should be mandatory. | ||
| + | </div> | ||
| + | |||
| + | <div> | ||
| + | <h2>Discussion with Felix Beck</h2> | ||
| + | </div> | ||
| + | <div> | ||
| + | Felix Beck is a Phd student from the University Freiburg. His thesis is about international environmental law and the international liability of new methods of molecular biology. In a skype call we discussed the legal situation of using and releasing GMOs in Germany and the EU with him. We had a closer look at the general concept of our system and debated whether it would be possible to use it in agriculture under the current legal framework. We concluded that, while it was theoretically possible, if it passed the risk assessments on the EU level, it was unlikely due to the creation of GMOs in the environment. | ||
| + | |||
| + | On April 12th we skyped with Felix Beck from the University Freiburg. He makes is active in the area of international environmental law and writes his Phd about international liability, focused on the new methods of molecular biology. | ||
| + | We got in touch with Felix to learn how likely it would be that our system could ever be used in Europe and if so, which requirements we would have to keep in mind. | ||
| + | Felix told us, that viruses and phages can be considered genetically modified organisms in the EU, even though this might not directly correspond with the biological definition of an organism. However, anything that can pass on DNA is considered an organism under EU law. This is mostly based on the idea that, since they can have the same effect as other GMOs like bacteria, they should be regulated just as strictly. | ||
| + | We also discussed with Felix, that lawmakers and biologists should work closer together when it comes to drafting laws that are sensible and represent the biologic reality. Often, lawmakers are unaware of the processes happening in labs, while biologists do not understand the law well. | ||
| + | In general, genetically modified organisms are considered to be dangerous at first, until it has been proven that they are not and do not express risks for the environment, animals or humans. | ||
| + | This is regulated on different plains: The first relevant law is the German law on genetic engineering. This one has been drafted according to the European directives and regulations, representing the European legislation – the “Release Directive” 2001/08, the directive for using GMOs in closed of systems, the export control and laws for food and feed as well as the convention for biodiversity. | ||
| + | Lastly, politicians are the ones who craft and implement the laws that they consider to be sensible and wanted by society. | ||
| + | The right of initiative within the EU lies with the European commission, that plays also a major part in allowing the release of specific GMOs under the Directive 2001/08. Before they can decide to allow or ban a certain GMO from being released, the European Food Safety Agency (EFSA) has to conduct tedious risk assessments. We learnt that these are being done by scientist, especially from the field of genetics and ecology, are part of these expert committees. | ||
| + | Felix explained that, in addition to this Directive 2001/08, another relevant law was implemented in 2013: the opt-out rule. It enables countries that do not want to cultivate certain GMOs to opt-out of allowing plants that are free to be released according to directive 2001/08. | ||
| + | Another more recent update of the law took place when the European Justice Court ruled that organisms that contain DNA modified by well-established techniques, like random mutagenesis, are not considered GMO, while any organism that is created or changed using more novel techniques like CRISPR is. This is something we also discussed with Felix. From our point of view, this ruling does not make any sense. While making it harder to rationally construct the best possible option of a certain plant or microorganism, it does not restrict the use of random mutagenesis and selection to gain the best variety possible. The issue that we see with that is that biologically identical organisms might be regulated differently, depending on which technique was used to produce them – and at that point, the law just does not reflect the biological reality. | ||
| + | After learning a lot from Felix about the general legal situation in the EU we started talking about our project and were astonished to hear that the law does not yet include recommendations for action when introducing a genetically modified virus into the environment, it does not foresee genetic engineering to take place outside of laboratories. Due to that, Felix could not explain directly, how a possible legalization of a system like that would take place – he did however state, that we would probably have to do two risk assessments: one for our Troygenics and one for the final transformed fungus – and that they would probably just pass, if the fungi die almost immediately after receiving the DNA from the Troygenic, as they could not be able to pass on this genetic modification. | ||
| + | The next issue that Felix would see is the integration of the Troygenic DNA into the fungal genome. While we agreed upon the fact that integrating the change into the genome would make it more likely that the organism changes to a greater degree and passes the modifications on to the next generation. Moreover, one cannot guarantee that no off-site genome integration takes place – no matter whether it is intended or not. That is why, while we decided to keep using genomic integration as a selection marker in the lab, we also started thinking about encoding our system on a plasmid that is maintained within the cell. However, this would most likely minimize the efficiency of our CeDIS, since it is easier for fungi to dispose of a plasmid that damages them, than discarding a gene that is implemented in their genome. | ||
| + | Felix also suggested that we could check-out the legal situation of the use of gene drives, as those are probably the most similar system to our Troygenics and the legislations might apply. | ||
| + | We additionally discussed the reasons for such a strict legal framework in Germany and the EU. We learnt that it is mostly caused by people’s fears of GMOs and a lack of education about the biologic principles. Felix believed, that it is important for scientists to communicate possible risks of their research, allowing an honest debate about whether it might be sensible to use it or not. Based on this honesty, people might also trust in science and the scientists rather then when they just stated that their research was safe and there was nothing to worry about. This could lead to a broader acceptance of novel techniques and less fear of the unknown. | ||
| + | |||
| + | </div> | ||
| + | |||
| + | </div> | ||
</div> | </div> | ||
| Line 1,779: | Line 2,197: | ||
<details> | <details> | ||
<summary> References </summary> | <summary> References </summary> | ||
| − | <p> | + | <p><a href="http://www.moa.gov.cn/ztzl/zjyqwgz/spxx/201901/P020190108439855980836.pdf">[1] http://www.moa.gov.cn/ztzl/zjyqwgz/spxx/201901/P020190108439855980836.pdf</a> </p> |
| − | + | <p><a href="https://www.isaaa.org/resources/publications/briefs/53/executivesummary/default.asp"> [2] https://www.isaaa.org/resources/publications/briefs/53/executivesummary/default.asp</a> </p> | |
| − | + | <p><a href="https://www.cell.com/trends/biotechnology/fulltext/S0167-7799(19)30037-X">[3] https://www.cell.com/trends/biotechnology/fulltext/S0167-7799(19)30037-X</a> </p> | |
| − | + | <p><a href="https://law.ucla.edu/~/media/Files/UCLA/Law/Pages/Publications/RES_PUB_GMO.ashx">[4] https://law.ucla.edu/~/media/Files/UCLA/Law/Pages/Publications/RES_PUB_GMO.ashx</a> </p> | |
| − | + | <p><a href="http://www.fao.org/food/food-safety-quality/gm-foods-platform/browse-information-by/country/country-page/en/?cty=CHN">[5] http://www.fao.org/food/food-safety-quality/gm-foods-platform/browse-information-by/country/country-page/en/?cty=CHN</a> </p> | |
| + | <p><a href="http://www.isaaa.org/gmapprovaldatabase/advsearch/default.asp?CropID=Any&TraitTypeID=Any&DeveloperID=Any&CountryID=IN&ApprovalTypeID=Any">[6] http://www.isaaa.org/gmapprovaldatabase/advsearch/default.asp?CropID=Any&TraitTypeID=Any&DeveloperID=Any&CountryID=IN&ApprovalTypeID=Any</a> </p> | ||
| + | <p><a href="https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12919-018-0106-0/MediaObjects/12919_2018_106_Fig1_HTML.png?as=webp">[7] https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12919-018-0106-0/MediaObjects/12919_2018_106_Fig1_HTML.png?as=webp</a> </p> | ||
| + | <p><a href="http://www.fao.org/food/food-safety-quality/gm-foods-platform/browse-information-by/country/country-page/en/?cty=IND">[8] http://www.fao.org/food/food-safety-quality/gm-foods-platform/browse-information-by/country/country-page/en/?cty=IND</a> </p> | ||
| + | <p><a href="https://www.fas.usda.gov/data/egypt-agricultural-biotechnology-annual-2018">[9] https://www.fas.usda.gov/data/egypt-agricultural-biotechnology-annual-2018</a> </p> | ||
| + | <p><a href="https://www.tandfonline.com/doi/pdf/10.4161/gmcr.1.3.12811">[10] https://www.tandfonline.com/doi/pdf/10.4161/gmcr.1.3.12811</a> </p> | ||
| + | <p><a href="http://www.fao.org/food/food-safety-quality/gm-foods-platform/browse-information-by/country/country-page/en/?cty=EGY">[11] http://www.fao.org/food/food-safety-quality/gm-foods-platform/browse-information-by/country/country-page/en/?cty=EGY</a> </p> | ||
| + | <p><a href="http://www.jordbruksverket.se/amnesomraden/odling/genteknikgmo/faltforsok/faltforsok2019.4.14c93023169b064e1e0408ed.html"> [12] http://www.jordbruksverket.se/amnesomraden/odling/genteknikgmo/faltforsok/faltforsok2019.4.14c93023169b064e1e0408ed.html</a> </p> | ||
| + | <p><a href="https://pdfs.semanticscholar.org/de33/b0c954d71d2f1f0e2148213d545fe848106d.pdf">[13] https://pdfs.semanticscholar.org/de33/b0c954d71d2f1f0e2148213d545fe848106d.pdf </a> </p> | ||
| + | |||
| + | <p><a href="http://www.fao.org/food/food-safety-quality/gm-foods-platform/browse-information-by/country/country-page/en/?cty=SWE">[14] http://www.fao.org/food/food-safety-quality/gm-foods-platform/browse-information-by/country/country-page/en/?cty=SWE</a> </p> | ||
| + | <p><a href="http://www.ogtr.gov.au/internet/ogtr/publishing.nsf/Content/cr-1/">[15] http://www.ogtr.gov.au/internet/ogtr/publishing.nsf/Content/cr-1/</a> </p> | ||
| + | <p><a href="http://www.ogtr.gov.au/internet/ogtr/publishing.nsf/Content/process-1">[16] http://www.ogtr.gov.au/internet/ogtr/publishing.nsf/Content/process-1</a> </p> | ||
| + | <p><a href="http://www.foodstandards.gov.au/consumer/gmfood/labelling/pages/default.aspx">[17] http://www.foodstandards.gov.au/consumer/gmfood/labelling/pages/default.aspx</a> </p> | ||
| + | <p><a href="https://www.ers.usda.gov/webdocs/publications/93026/eib-208.pdf#page=36">[18] https://www.ers.usda.gov/webdocs/publications/93026/eib-208.pdf#page=36</a> </p> | ||
| + | <p><a href="https://www.aphis.usda.gov/biotechnology/downloads/permit_guidance.pdf">[19] https://www.aphis.usda.gov/biotechnology/downloads/permit_guidance.pdf</a> </p> | ||
| + | <p><a href="https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-09389.pdf">[20] https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-09389.pdf</a> </p> | ||
| + | |||
| + | <p><a href="https://zag.bvl.bund.de/freisetzungen/index.jsf?dswid=4474&dsrid=91">[21] https://zag.bvl.bund.de/freisetzungen/index.jsf?dswid=4474&dsrid=91</a> </p> | ||
| + | <p><a href="https://www.bfn.de/fileadmin/MDB/documents/eu_memo-04-85.pdf">[22] https://www.bfn.de/fileadmin/MDB/documents/eu_memo-04-85.pdf</a> </p> | ||
| + | <p><a href="https://www.bvl.bund.de/SharedDocs/Downloads/06_Gentechnik/00_allgemein/poster_freisetzungen.html?nn=1477570">[23] https://www.bvl.bund.de/SharedDocs/Downloads/06_Gentechnik/00_allgemein/poster_freisetzungen.html?nn=1477570</a> </p> | ||
| + | <p><a href="https://cib.org.br/aprovacoes-da-ctnbio/">[24] https://cib.org.br/aprovacoes-da-ctnbio/</a> </p> | ||
| + | <p><a href="https://cib.org.br/top-5-area-cultivada-com-transgenicos-no-mundo/"> [25] https://cib.org.br/top-5-area-cultivada-com-transgenicos-no-mundo/</a> </p> | ||
| + | <p><a href="http://ctnbio.mcti.gov.br/regimento-interno-da-ctnbio">[26] http://ctnbio.mcti.gov.br/regimento-interno-da-ctnbio</a> </p> | ||
| + | <p><a href="http://www.planalto.gov.br/ccivil_03/decreto/2003/d4680.htm">[27] http://www.planalto.gov.br/ccivil_03/decreto/2003/d4680.htm</a> </p> | ||
| + | <p><a href="https://www.efsa.europa.eu/sites/default/files/consultation/gmo101129%2C0.pdf">[28] https://www.efsa.europa.eu/sites/default/files/consultation/gmo101129%2C0.pdf</a> </p> | ||
| + | <p><a href="http://www.fao.org/food/food-safety-quality/gm-foods-platform/browse-information-by/country/country-page/en/?cty=GBR">[29] http://www.fao.org/food/food-safety-quality/gm-foods-platform/browse-information-by/country/country-page/en/?cty=GBR</a> </p> | ||
| + | <p><a href="https://www.isaaa.org/resources/publications/briefs/53/executivesummary/default.asp"> [30] https://www.isaaa.org/resources/publications/briefs/53/executivesummary/default.asp</a> </p> | ||
| + | <p><a href="https://www.isaaa.org/resources/publications/briefs/53/executivesummary/default.asp">[31] https://www.isaaa.org/resources/publications/briefs/53/executivesummary/default.asp</a> </p> | ||
| + | <p><a href="https://www.loc.gov/law/help/restrictions-on-gmos/canada.php#_ftn49">[32] https://www.loc.gov/law/help/restrictions-on-gmos/canada.php#_ftn49 </a> </p> | ||
| + | <p><a href="https://www.isaaa.org/resources/publications/briefs/53/executivesummary/default.asp">[33] https://www.isaaa.org/resources/publications/briefs/53/executivesummary/default.asp</a> </p> | ||
| + | <p><a href="https://www.canada.ca/en/health-canada/services/food-nutrition/genetically-modified-foods-other-novel-foods/factsheets-frequently-asked-questions/part-1-regulation-novel-foods.html#p3">[34] https://www.canada.ca/en/health-canada/services/food-nutrition/genetically-modified-foods-other-novel-foods/factsheets-frequently-asked-questions/part-1-regulation-novel-foods.html#p3 </a></p> | ||
| + | |||
</details> | </details> | ||
| Line 1,819: | Line 2,269: | ||
var $circDrei= $('.animated-circle-drei'); | var $circDrei= $('.animated-circle-drei'); | ||
var $circVier= $('.animated-circle-vier'); | var $circVier= $('.animated-circle-vier'); | ||
| − | + | //var $progCount = $('.progress-count'); | |
| − | + | //var $prog2 = $('.progress-indicator-2'); | |
| + | // var $progCountZwei = $('.progress-count-zwei'); | ||
| + | // var $progCountDrei = $('.progress-count-drei'); | ||
| + | // var $prog3= $('.progress-indicator-3'); | ||
| − | var wh, h, sHeight, partOne, partTwo, partThree, partFour | + | var wh, h, sHeight, partOne, partTwo, partThree, partFour; |
function setSizes1(){ | function setSizes1(){ | ||
| Line 1,828: | Line 2,281: | ||
s=$("#a1").offset().top+$(window).innerHeight(); //ist der Abstand vom Anfang der Seite bis nach der Summary | s=$("#a1").offset().top+$(window).innerHeight(); //ist der Abstand vom Anfang der Seite bis nach der Summary | ||
s2=$("#a2").offset().top+$(window).innerHeight();//+140; //Erster Abschnitt h1- H2 | s2=$("#a2").offset().top+$(window).innerHeight();//+140; //Erster Abschnitt h1- H2 | ||
| − | s3=$("#a3").offset().top+$(window).innerHeight() | + | s3=$("#a3").offset().top+$(window).innerHeight()-50; |
| − | s4 | + | s4=($("#Ende").offset().top)+250; //zweiter Abschnitt h2-h3 |
| − | + | ||
| − | + | ||
h = $('body').height()-$(window).innerHeight(); | h = $('body').height()-$(window).innerHeight(); | ||
partOne =s-wh; | partOne =s-wh; | ||
| Line 1,837: | Line 2,288: | ||
partThree=s3-(wh+partTwo+partOne); | partThree=s3-(wh+partTwo+partOne); | ||
partFour=s4-(wh+partThree+partTwo+partOne); | partFour=s4-(wh+partThree+partTwo+partOne); | ||
| − | |||
| − | |||
} | } | ||
| Line 1,848: | Line 2,297: | ||
var percThree = Math.max(0, Math.min(1, ($w.scrollTop()-partTwo-partOne)/partThree)); | var percThree = Math.max(0, Math.min(1, ($w.scrollTop()-partTwo-partOne)/partThree)); | ||
var percFour = Math.max(0, Math.min(1, ($w.scrollTop()-partThree-partTwo-partOne)/partFour)); | var percFour = Math.max(0, Math.min(1, ($w.scrollTop()-partThree-partTwo-partOne)/partFour)); | ||
| − | |||
| − | |||
| − | updateProgress1(percTwo,percThree,percFour | + | updateProgress1(percTwo,percThree,percFour); |
}).on('resize', function(){ | }).on('resize', function(){ | ||
setSizes1(); | setSizes1(); | ||
| Line 1,858: | Line 2,305: | ||
| − | function updateProgress1(percTwo,percThree,percFour | + | function updateProgress1(percTwo,percThree,percFour){ |
| − | + | var circle_offset = 63 * percTwo; | |
| + | //var circle_offset_eins = 126 * percOne; | ||
var circle_offset_zwei = 63 * percThree; | var circle_offset_zwei = 63 * percThree; | ||
var circle_offset_drei = 63 * percFour; | var circle_offset_drei = 63 * percFour; | ||
| − | |||
| − | |||
$circZwei.css({ | $circZwei.css({ | ||
"stroke-dashoffset" : 63 - circle_offset | "stroke-dashoffset" : 63 - circle_offset | ||
}); | }); | ||
| + | //$circ.css({ | ||
| + | // "stroke-dashoffset" : 126 - circle_offset_eins | ||
| + | //}); | ||
$circDrei.css({ | $circDrei.css({ | ||
"stroke-dashoffset" : 63 - circle_offset_zwei | "stroke-dashoffset" : 63 - circle_offset_zwei | ||
| Line 1,874: | Line 2,323: | ||
"stroke-dashoffset" : 63 - circle_offset_drei | "stroke-dashoffset" : 63 - circle_offset_drei | ||
}); | }); | ||
| − | + | // $progCountZwei.html(Math.round(percTwo * 100) + "%"); | |
| − | + | // $progCount.html(Math.round(percOne * 100) + "%"); | |
| − | + | // $progCountDrei.html(Math.round(percThree * 100) + "%"); | |
| − | + | // $prog2.css({width : perc*100 + '%'}); | |
| − | + | // $prog2.css({width : perc*100 + '%'}); | |
| − | + | // $prog2.css({width : perc*100 + '%'}); | |
| − | + | ||
| − | + | ||
| − | + | ||
} | } | ||
| Line 1,888: | Line 2,334: | ||
}()); | }()); | ||
| + | </script> | ||
| + | |||
| + | <script type="text/javascript"> | ||
| + | $('map').imageMapResize(); | ||
</script> | </script> | ||
Latest revision as of 23:29, 13 December 2019
All together, we came into contact with 50+ experts and stakeholders out of more than 18 different countries from all continents. Their contributions shaped our project into what it is now and the various backgrounds of our experts and their sometimes contradictory opinions elevated our project to a real-world application that aroused interests in farmers, mycologists and experts from the industry alike. For example, we discussed the optimisation of our proof of concept with Professor Dr. Mark Varrelmann from the Institute for sugar beet research (IfZ) at the University of Göttingen. He suggested us to extent our proof of concept and test our system for a filamentous fungus. As a result, we also tested our system in Aspergillus niger to closer resemble a crop pathogenic fungus. Furthermore, we were able to improve biosafety and biosecurity aspects of our project according to the legal situation, guidelines and suggestions for improvements through experts. By doing so, we made sure our Troygenics do not pose any harm for the environment or the consumer.
Expert opinions
General Experts
Skype Conference 04.07
Extended Phone call 23.08
Visit at Bayer Forward Farm in Rommerskirchen 26.09
In general, the risk of resistances being developed is strongly influenced by a sheer endless number of factors. Furthermore, there are many different fungicides with very different modes of action. Farmers try to avoid the progression of resistance development with multiple measures, for example switching fungicides or the order of their usage. Others use mixtures of different reagents. The chambers of agriculture have many suggestions for the usage of fungicides, but at the end farmers are responsible for their own decisions on how to use them, as long as they stick to the law. Besides his extensive support he also gave us the chance to visit the Bayer Forward Farm in Rommerskirchen, a testing area to educate people about agriculture, common methods and recent technological advances. It also resembles a specialised facility for people to get in touch with farmers and stakeholders.
The biggest current concern, regarding the off-target effects of fungicides is that triazole fungicides, which are targeting ERG11 (CYP51) in the ergosterol synthesis pathway in fungi, can have off-target effects on at least one enzyme involved in the hormone synthesis in mammals. These effects are still very small though and far below the level detectable by epidemiological analysis. The EU legislation still requires strictly no off-target effects on the mammalian reproductive system, by whatever method of testing.
Phone call 10.09
Video conference 13.09
Skype Conference 06.09
He suggested us to alternatively think about modifying mycoviruses for our project, which could be a focus of later research. He pointed out, that special bacteria, called Burkholderia, are able to express proteins which can destroy the cell walls of fungi. As far as they were researched, this worked in every fungus that was tested.
Phone call 19.08
Phone call 16.10
Skype conference 13.08
Mail contact 25.07
Mail contact 25.07
Skype conference 01.08
Skype Conference 02.10
Endocytosis
Skype conference 15.08
Phone call 06.08
Skype conference 26.08
Skype conference 27. 08
Mail with helpful papers attached: 30.8.
Skype conference 19.08
Phone call 02.08
Phone call 06.08
CeDIS
Skype conference 23.07
Phone call 15.08
Video conference 29.07
Demonstrate
Phone call 02.09
Phone call 21.06
Skype conference 04.09.
Modeling
Phone call: 28.08
Skype conference 03.09
Skype call 13.09
Agriculture
Mail contact 25.07
Skype conference 05.08
Phone call 11.09.
Visit at his farm and interview 17.09.
Phone call 23.09
Phone call 10.04
Visit at his farm and interview 23.08
11.09 extensive phone call
Forward Farm
The farm in Rommerskirchen is one of two locations in Germany where Bayer established a Forward Farm: An experimental testing area for novel approaches to solve problems in the field of agriculture. Thereby, the farm’s purpose is also to educate the public about farming and emerging technologies. The engagement with the public and the promotion of face to face interaction is one of the foundations the project is based on.
During our visit, we received extensive first-hand insights into agriculture from different points of views. The different experts who accompanied us each represented a different important aspect of modern agriculture.
Dr Patrick Beuters
Karl Eschenbacher
Bernd Olligs
Legal Situation
Legal situation: Point of view
Point of View: Germany
Coming from Germany, a country that strictly regulates the use of GMOs under any circumstances and does not allow any genetically modified organisms to be released, it was rather surprising, that there are countries that don’t only allow the release of GMOs, but have more than 100 kinds of genetically modified crops on the market. It was rather startling that in the USA the use of 130 genetically modified plants is not regulated anymore and that companies do not have to get permits or even notify the government that and where they are planting those GMOs. It left us even more surprised that there are several thousand more GMOs on the fields in the USA that are monitored and are not used in food, feed or any other application just yet. The fact that there are Genetically Modified Microorganisms (GMMs) with an authorization for release at all, totaling to 39 in Brazil and Australia, was another surprise to us. The rules set for risk assessments in the EU make it rather unlikely that a GMM would pass the regulatory process, no matter how many safety measures have been taken to construct a save organism and to prevent its spreading. Coming from a precautionary point of view, the tedious risk assessments ensure safety – and as unlikely as any negative consequences of releasing a GMM into the environment might be, the EU wants to prevent them without any doubt. Since eliminating the doubt is only possible, if the organism is not released, this is the option the EU usually choses. Seeing that other countries accept and live with that doubt, left us startled – most Germans would not be okay with those policies. Another thing that was rather new to us was that countries as the USA and Canada do not enforce the labeling of products that contain GMOs. While we are insecure about the clarity of the definition of GMO and the awareness that the regular consumer has towards this definition, transparency is considered to be incredibly important for democracy in Germany and in the EU. Even though the acts of authorities don’t always live up to the high expectancies for transparency among the people, this is often called out and complained about. Therefore, labeling the origin of products in the supermarket is important to many Germans, allowing for a more informed consumer decision. Whether this should also be true for GMO-products has to be discussed, mostly due to the varying definition of GMOs all over the world. Is an organism that is produced with random mutagenesis genetically modified? How about a cross-bred plant? What if a CRISPR/Cas system had been used? The definitions are different depending on the law – and vary even more widely on the minds of consumers. If a consumer does not properly understand a label, labeling GMO products might not lead to a more, but rather a less informed choice. However, we do believe that some kind of labeling, be it GMO or non-GMO or naming the plant variety that had been used might help the consumer to make an informed decision. That the legal situation in other countries enables the selling of GMO products without labeling them might be another approach that would not be accepted by many Germans due to the lack of transparency and the impact that this might have on their informed decisions.Point of View: Brazil
In Brazil, we’re used to GM crops, since over 50 Million hectares are destined to growing GM crops. Recently, approval of agrochemicals mainly destined to GM cultivations, such as glyphosate-based herbicides in the news frequently. Furthermore, labelling GM products is mandatory in Brazil and is often discussed in recent times. Overall, we find it very difficult to find data about GMOs. We expected this would be easier given its importance for food as well as for the development of new technologies in health and for the environment. Considering the high number of GMO crops and the application of GMMs and even GM animals in Brazil the legislation is one of the most flexible in the world, allowing GMOs use, different from what we thought, due to the general bureaucracy in the country. The most remarkable feature in the GMO legislation for Australia is the restriction of GMO crop cultivation, since 61% of the Australian landmass is not suitalbe for agricultural production. Therefore, using GM crops to improve the production efficiency might be interesting for the country. We knew that GMO legislation in the European Union is much stricter than the one we have in Brazil, so we expected that no transgenic plants would be grown in Sweden and England, and that the labelling of GMO products would be mandatory in both countries. We find it amazing that there is a lot of research on GMMs in Swedish high schools. Besides that, we were stunned when reading about the case of the Amflora potato in the country. Approval took a long time when the swedes began producing it, the crops were contaminated by another unauthorized GMO potato. Therefore, they stopped growing the potato and the responsible company stopped all further activities in the country! This is not common in Brazil: when an environmental disaster happens, the responsible companies do not shut down… When reading about the UK, we were surprised by Boris Johnson's recent quote about the GMO production there: “Let's liberate the UK's extraordinary bioscience sector from anti-genetic modification rules." We did not imagine this stance, as there is a strong anti-GMO culture in the UK and all current crop cultivations are non-transgenic. May this be the starting point for Europe to change its mind about GMOs? It was surprising to us that Egypt forbids GMO cultivation, although it imports many GMOs varieties. Given its arid climate, we were sure that there would be some GMO production that would dodge this circumstance. In addition, the anti-GMO mindset appears to be quite strong, as well as incidences of illegal use of toxic substances in agricultural production. Regarding India, we found it impressive that the governing laws about GMOs were very old: from 1989. However, it is not always respected, and the problems of irreversible cross-contamination due to the illegal cultivation of other GMO varieties are recurrent. We were surprised that the only variety allowed for cultivation is cotton. In addition, we think it is progressive for the country to allow research with Oxitec and GM silkworms mosquitoes. It was unexpected to find that Canada does not require mandatory labelling of genetically modified foods. It is voluntary, unless there is an explicit health or safety concern. As one of the main producers of GM crops, there are movements of those in the country who believe the labelling should be mandatory. On the other hand, it was interesting to find that China - also one of the largest producers of GM crops - needs, on average, much less time to get a GMO approved, even though the project has to go through three main institutions to do so. Makes us wonder about the bureaucracy in other countries, that require 7 to 11 years to get a GM crop approved such as in Brazil. Furthermore, as a study from 2018 points out, almost half of the Chinese population have a negative perception of genetically modified foods, which may explain the mandatory labelling of GM foods in the country.GMO legislations in several countries
Discussion with Felix Beck
References
[1] http://www.moa.gov.cn/ztzl/zjyqwgz/spxx/201901/P020190108439855980836.pdf
[2] https://www.isaaa.org/resources/publications/briefs/53/executivesummary/default.asp
[3] https://www.cell.com/trends/biotechnology/fulltext/S0167-7799(19)30037-X
[4] https://law.ucla.edu/~/media/Files/UCLA/Law/Pages/Publications/RES_PUB_GMO.ashx
[9] https://www.fas.usda.gov/data/egypt-agricultural-biotechnology-annual-2018
[10] https://www.tandfonline.com/doi/pdf/10.4161/gmcr.1.3.12811
[13] https://pdfs.semanticscholar.org/de33/b0c954d71d2f1f0e2148213d545fe848106d.pdf
[15] http://www.ogtr.gov.au/internet/ogtr/publishing.nsf/Content/cr-1/
[16] http://www.ogtr.gov.au/internet/ogtr/publishing.nsf/Content/process-1
[17] http://www.foodstandards.gov.au/consumer/gmfood/labelling/pages/default.aspx
[18] https://www.ers.usda.gov/webdocs/publications/93026/eib-208.pdf#page=36
[19] https://www.aphis.usda.gov/biotechnology/downloads/permit_guidance.pdf
[20] https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-09389.pdf
[21] https://zag.bvl.bund.de/freisetzungen/index.jsf?dswid=4474&dsrid=91
[22] https://www.bfn.de/fileadmin/MDB/documents/eu_memo-04-85.pdf
[24] https://cib.org.br/aprovacoes-da-ctnbio/
[25] https://cib.org.br/top-5-area-cultivada-com-transgenicos-no-mundo/
[26] http://ctnbio.mcti.gov.br/regimento-interno-da-ctnbio
[27] http://www.planalto.gov.br/ccivil_03/decreto/2003/d4680.htm
[28] https://www.efsa.europa.eu/sites/default/files/consultation/gmo101129%2C0.pdf
[30] https://www.isaaa.org/resources/publications/briefs/53/executivesummary/default.asp
[31] https://www.isaaa.org/resources/publications/briefs/53/executivesummary/default.asp
[32] https://www.loc.gov/law/help/restrictions-on-gmos/canada.php#_ftn49
[33] https://www.isaaa.org/resources/publications/briefs/53/executivesummary/default.asp